Clinical Trial Update: Demographics, Clinical Outcomes, and Physician Attitudes in Patients Who Have Received The MiCK Assay (CorrectChemo)

View source ↗

Summary

The clinical trial NCT02137811 evaluating the MiCK Assay (CorrectChemo) sponsored by Pierian Biosciences has been withdrawn, with no further results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Pierian Biosciences | Conditions: Cancer | Status: WITHDRAWN